Acute myocardial infarction in pregnant women

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 3, 2010, Pages 247-253

  Poh, Chin Leng ^a   Lee, Chi Hang ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Myocardial infarction; Obstetric labour complications; Pregnancy complications

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; NIFEDIPINE; NITRIC ACID DERIVATIVE; OXYTOCIN; PROTAMINE SULFATE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; AGING; ALLERGIC REACTION; ANGIOCARDIOGRAPHY; APNEA; BARE METAL STENT; BLEEDING; BLOOD CLOTTING; BLOOD TRANSFUSION; BRADYCARDIA; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SPASM; CORONARY REPERFUSION; CORONARY STENT; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG MILK LEVEL; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; FETOTOXICITY; FETUS OUTCOME; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; HYPOTENSION; LABOR COMPLICATION; LABOR INDUCTION; LOW DRUG DOSE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MITRAL VALVE STENOSIS; MULTIPARA; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PUERPERAL INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 77950874990     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Ladner HE, Danielson B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynaecol 2005;105:480-4.
2. Badui E, Enciso R. Acute myocardial infarction during pregnancy and puerperium: a review. Angiology 1996;47:739-56.
3. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK. Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006;113:1564-71.
4. Dwyer B, Taylor L, Fuller A, Brummel C, Lyell DJ. Percutaneous transluminal coarony angioplasty and stent placement in pregnancy. Obestet Gynaecol 2005;106:1162-4.
5. Anon. Why Mothers Die 2000-2002. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: Royal College of Obstetrics and Gynaecology Press 2004.
6. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008;52:171-80.
7. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 1996;125:751-62.
8. Pierre-Louis B, Singh P, Frishman WH. Acute inferior wall myocardial infarction and percutaneous coronary intervention of the right coronary during active labor - a clinical report and review of the literature. Cardiol Rev 2008;16:260-8.
9. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-9.
10. Nisell H, Hjemdahl P, Linde B. Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clin Physiol 1985;5:479-93.
11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
12. Sasse L, Wagner R, Murray FE. Transmural myocardial infarction during pregnancy. Am J Cardiol 1975;35:448-52.
13. Iffy L, TenHove W, Frisoli G. Acute myocardial infarction in the pueriperium in patients receiving bromocriptine. Am J Obstet Gynecol 1986;155:371-2.
14. Sonel A, Erol C, Oral D, Omurlu K, Akyol T, Kaymakcalan S. Acute myocardial infarction and normal coronary arteries in a pregnant woman. Cardiology 1988;75:218-20.
15. Yoshimura T, Ito M, Nakamura T, Okamura H. The influence of labor on thrombotic and fibrinolytic systems. Eur J Obstet Gynaecol Reprod Biol 1992;44:195-9.
16. Baughman KL. The Heart and Pregnancy. In: Topol EJ, Califf RM, editors. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott Williams & Wilkins, 2006.
17. Colman JM, Silversides CK, Sermer M, Siu SC. Cardiac monitoring during pregnancy. In: Steer PJ, Gatzoulis MA, Baker P, editors. Heart Disease and Pregnancy. London: RCOG Press, 2006.
18. Moran C, Ni Bhuinnedin M, Geary M, Cunningham S, McKenna P, Gardiner J. Myocardial ischemia in normal patients undergoing elective cesarean section: a peripartum assessment. Anaesthesia 2001;56:1051-8.
19. Sheik AU, Harper MA. Myocardial infarction during pregnancy: management and outcome of two pregnancies. Am J Obstet Gynecol 1993;169:279-84.
20. Bithell JF, Stewart AM. Pre-natal radiation and childhood malignancy: a review of British data from the Oxford survey. Br J Cancer 1975;31: 271-87.
21. Brent RL. The effect of embryonic and fetal exposure to X-ray,microwaves, and ultrasound: counseling the pregnant and nonpregnant patients about these risks. Semin Oncol 1989;16:347-68.
22. Colletti PM, Lee K. Cardiovascular imaging in the pregnant patient In: Elkayam U, Gleicher N, editors. Cardiac Problems in Pregnancy. New York: Wiley-Liss, 1998.
23. King SB 3rd, Smith SCJ, Hirshfeld JWJ, Jacobs AK, Morrison DA, Williams DO. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2007 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee. Circulation 2008;117:261-95.
24. Cuthill JA, Young S, Greer IA, Oldroyd K. Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean section. Int J Obstet Anesth 2004;14:167-71.
25. Pfeifer GW. Distribution studies on placental transfer of 131I streptokinase during labour. Ann Med 1970;19:17-8.
26. Lecander I, Nilsson M, Astedt T. Depression of plasminogen activator activity during pregnancy by the placental inhibitor PAI 2. Fibrinolysis 1988;2:165-7.
27. Schumacher B, Belfort MA, Card RJ. Sucessful treatment of actue myocardial infarction during pregnancy with tissue plasminogen activator. Am J Obstet Gynecol 1997;176:716-9.
28. Koul AK, Hollander G, Moskovits N, Frankwl R, Herrera L, Shani J. Coronary artery dissection during pregnancy and the postpartum period: two case reports and review of literature. Catheter Cardiovasc Interv 2001;52:88-94.
29. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, et al. Regional anesthesia in the anticoagulated patient: defining the risks. The Second American Society of Regional Anesthesia Consensus Conference on Neuraxial Anesthesia and Anticoagulation. Reg Anesth Pain Med 2003;28:172-97.
30. Bernal JM, Miralle PJ. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obestet Gynecol Surv 1986;41:1-6.
31. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Associations of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007;50:e1-157.
32. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008;51:960-9.
33. Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmacotheraputic considerations during pregnancy and lactation. Part 2. Cardiol Rev 2004;12:240-61.
34. Bullarbo M, Tjumum J, Ekerhovd E. Sublingual nitroglycerin for management of retained placenta. Int J Gynaecol Obstet 2005;91:228-32.
35. Calvin SE. Use of vasodilators during pregnancy. In: Elkayam U, Gleicher N, editors. Cardiac Problems in Pregnancy Diagnosis and Management of Maternal and Fetal Heart Disease. New York: Wiley-Liss, 1998.
36. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Philadelphia: Lippincott Williams & Wilkins, 2005.
37. Shotan A, Widerhorn J, Hurst AK, Elkayam U. Angiotensin-converting enzyme inhibitors and pregnancy. In: Elkayam U, Gleicher N, editors. Cardiac Problems in Pregnancy: Diagnosis and Management of Maternal and Fetal Disease. 3rd ed. New York: Wiley-Liss, 1998:399-406.
38. Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmacotheraputic considerations during pregnancy and lactation. Cardiol Rev 2004;12:240-61.
39. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks of specific birth defects: A population-based case-control study. Pediatrics 1990;85:1-9.
40. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 2007;161:745-50.
41. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:627s-44s.
42. Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004;92:747-51.
43. Kahler C, Schleussmer E, Moller A, Seewald HJ. Nitric oxide donors: effects on fetoplacental blood flow. Eur J Obstet Gynaecol Reprod Biol 2004;115:10-4.
44. CLASP. A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619-29.
45. Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266:260-4.
46. Lang RM, Lampert MB, Poppas A, et al. Peripartal cardiomyopathy. In: Elkayam U, Gleicher N, editors. Cardiac Problems in Pregnancy: Diagnosis and Management of Maternal and Fetal Disease. New York: Wiley-Liss, 1998.